Screening for abdominal aortic aneurysm

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Cosford, Paul ^a   Leng, G C ^b  

^a East of England Strategic Health Authority   (United Kingdom)

^b NONE

Author keywords

*Mass screening economics ; Aged; Aged, 80 and over; Aortic aneurysm, abdominal *diagnosis; mortality; surgery ; Cost benefit analysis; Female; Humans; Life expectancy; Male; Randomized controlled trials as topic; Sex factors

Indexed keywords

MACROLIDE; PROPRANOLOL; ROXITHROMYCIN;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DENMARK; DISEASE COURSE; DRUG FATALITY; DRUG MECHANISM; DYSPNEA; ELECTIVE SURGERY; EMERGENCY CARE; FOLLOW UP; HEALTH CARE COST; HUMAN; LUNG FUNCTION; MORBIDITY; MORTALITY; OUTPATIENT CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEX DIFFERENCE; SIDE EFFECT; ULTRASOUND; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VASCULAR SURGERY;

EID: 34648827737     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002945.pub2     Document Type: Review

References (49)

1. Chichester {published data only} Bryan S, Buxton M, McKenna M, Ashton H, Scott A. Private costs associated with abdominal aortic aneurysmscreening: the importance of private travel and time costs [see comments]. Journal of Medical Screening 1995;2(2):62-6.
2. Couto E, Duffy SW, Ashton HA, Walker NM, Myles JP, Scott RA, et al.Probabilities of progression of aortic aneurysms: estimates and implications for screening policy. Journal of Medical Screening 2002;91(1):40- 2.
3. Scott RA, Bridgewater SG, Ashton HA. Randomized clinical trial of screening for abdominal aortic aneurysm in women. British Journal of Surgery 2002;89(3):283-5.
4. Scott RA, Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA. The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65. European Journal of Vascular & Endovascular Surgery 2001;21(6):535-40.
5. *Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. British Journal of Surgery 1995;82(8):1066-70.
6. Scott RAP, Wilson NM, Ashton HA, Kay DN. The 5-year results of a control study of screening for aortic aneurysm. British Journal of Surgery 1995;82:561.
7. Vardulaki KA, Prevost TC, Walker NM, Day NE, Wilmink AB, Quick CR, et al.Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases. Journal of Medical Screening 1999;6(1):50-4.
8. Vardulaki KA, Walker NM, Couto E, Day NE, Thompson SG, Ashton HA, et al.Late results concerning feasibility and compliance from a randomized trial of ultrasonographic screening for abdominal aortic aneurysm. British Journal of Surgery 2002;89(7):861-4.
9. Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA, Scott RA. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. British Journal of Surgery 2000;87(2):195-200.
10. MASS {published data only} Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360(9345):1531-9.
11. Kim LG, Scott RA, Thompson SG, Collin J, Morris GE, Sutton GL, Wilson NM, Multicentre-Aneurysm-Screening-Study-Group. Implications of screening for abdominal aortic aneurysms on surgical workload. British Journal of Surgery 2005;92(2):171-6.
12. Multicentre Aneurysm Screening Study Group. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results fromrandomised controlled trial.[comment]. BMJ 2002;325(7373):1135.
13. Viborg {published data only} Lindholt J, Juul S, Fasting H, Henneberg E. Costs, benefits, and effectiveness of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. European Society for Vascular Surgery, Programme and Abstract Book, XVII Annual Meeting and Course on Vascular Surgical Techniques. 2003; Vol. 63.
14. Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. British Journal of Surgery 2001;88(11):1472-5.
15. Lindholt JS, Fasting H, Henneberg EW, Juul S. [Preliminary results of screening for abdominal aortic aneurysmin the county of Viborg]. [Danish]. Ugeskrift for Laeger 1997;159(13):1920-3.
16. Lindholt JS, Henneberg EW, Fasting H, Juul S. Hospital based screening of 65-73 year old men for abdominal aortic aneurysms in the county of Viborg, Denmark. Journal of Medical Screening 1996;3(1):43-6.
17. Lindholt JS, Juul S, Fasting H, Henneberg EW. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. European Journal of Vascular & Endovascular Surgery 2002;23(1):55-60.
18. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005;330(7494):750-3.
19. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening reduced abdominal aortic aneurysm mortality - secondary publication. Results from a Danish randomized screening trial. Ugeskrift for Laeger 2005;167(15): 1641-4.
20. Lindholt JS, Juul S, Fasting H, Vammen S, Henneberg EW. Hospital costs and benefits of screening for abdominal aortic aneurysm. Results from a randomized screening trial. Ugeskrift for Laeger 2003;165(6):579- 83.
21. Lindholt JS, Juul S, Henneberg EW, Fasting H. Is screening for abdominal aortic aneurysm acceptable to the population? Selection and recruitment to hospital-based mass screening for abdominal aortic aneurysm. Journal of Public Health Medicine 1998;20(2):211-7.
22. Lindholt JS, Vammen S, Henneberg EW, Fasting H, Juul S. [Optimal interval screening and observation of abdominal aortic aneurysms]. [Danish]. Ugeskrift for Laeger 2001;163(37):5034-7.
23. Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. European Journal of Vascular & Endovascular Surgery 1999;17(6):472-5.
24. Western Australia {published data only} *Jamrozik K, Norman PE, Spencer CA, Parsons RW, Tuohy R, Lawrence-Brown MM, et al.Screening for abdominal aortic aneurysm: lessons from a population-based study. Medical Journal of Australia 2000;173(7):345-50. Medical Journal of Australia 2000;173(7):345-50.
25. Lawrence-Brown MM, Norman PE, Jamrozik K, Semmens JB, Donnelly NJ, Spencer C, et al.Initial results of ultrasound screening for aneurysm of the abdominal aorta in Western Australia: relevance for endoluminal treatment of aneurysm disease. Cardiovascular Surgery 2001;9(3):234-40.
26. Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al.Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329(7477):1259- 1264.
27. Spencer CA, Jamrozik K, Norman PE, Lawrence-Brown MM. The potential for a selective screening strategy for abdominal aortic aneurysm. Journal of Medical Screening 2000;7(4):209-11.
28. Lindholt 1999 Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. International Angiology 1999;18(1):52-7.
29. Lindholt 2000 Lindholt JS, Vammen S, Fasting H, Henneberg EW. Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small abdominal aortic aneurysms. European Journal of Vascular & Endovascular Surgery 2000;20(1):79-83.
30. Vammen 2001 Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. British Journal of Surgery 2001;88(8):1066-72.
31. Vammen 2002 Vammen S, Lindholt JS, Ostergaard LJ, Fasting H, Henneberg EW. Reduction of the expansion rate of small abdominal aortic aneurysms with roxithromycin. Results from a randomized controlled trial. Ugeskrift for Laeger 2002;164(50):5916-9.
32. Anonymous 1998 Anonymous. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998;352(9141):1649-55.
33. Ballard 2000 Ballard DJ, Fowkes FGR, Powell JT. Surgery for small asymptomatic abdominal aortic aneurysms (Cochrane Review). Cochrane Database of Systematic Reviews 2000, Issue 3.Art. No.: CD001835. DOI:10.1002/ 14651858.CD001835.
34. Basnyat 1999 Basnyat PS, Biffin AH, Moseley LG, Hedges AR, Lewis MH. Mortality from ruptured aortic aneurysmin Wales. British Journal of Surgery 1999;86(6):765-770.
35. Brown 1999 Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Annals of Surgery 1999;230(3):289-97.
36. Ernst 1993 Ernst CB. Abdominal aortic aneurysm. New England Journal of Medicine 1993;328(16):1167-72.
37. Health Dept 1998 Screening Committee. Health Departments of the United Kingdom. First report of the National Screening Committee. www.nsc.nhs.uk/pdfs/nsc_firstreport.pdf 1998 (accessed 11 November 2006).
38. Health Dept 2000 UK National Screening Committee. Health Departments of the United Kingdom. Second report of the UK National Screening Committee. www.nsc.nhs.uk/pdfs/secondreport.pdf 2000 (accessed 11 November 2006).
39. Health Dept 2006 UK National Screening Committee. Abdominal aortic aneurysm, National Screening Committee policy decision February 2006. National Library for Health Specialist Library - screening (www.library.nhs.uk/screening) 2006.
40. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al.Assessing the quality of reports of randomised clnical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
41. Jamrozik 2000 Jamrozik K, Norman PE, Spencer CA, Parsons RW, Tuohy R, Lawrence-Brown MM, et al.Screening for abdominal aortic aneurysm: lessons from a population-based study. Medical Journal of Australia 2000;173(7):345-50. Medical Journal of Australia 2000;173(7):345-50.
42. Johnston 1994 Johnston KW. Ruptured aortic aneurysm: six year follow up results of a multi-center prospective study. Canadian Society for Vascular Surgery Aneurysm Study Group. Journal of Vascular Surgery 1994;19(5):888-900.
43. Lindholt 1996 Lindholt JS, Henneberg EW, Fasting H, Juul S. Hospital based screening of 65-73 year old men for abdominal aortic aneurysms in the county of Viborg, Denmark. Journal of Medical Screening 1996;3(1):43-46. [MEDLINE: 4406].
44. Lindholt 2002 Lindholt JS, Juul S, Fasting H, Henneberg EW. Hospital costs and benefits of screening for abdominal aortic aneurysms. Results from a randomised population screening trial. European Journal of Vascular & Endovascular Surgery 2002;23(1):55-60.
45. Norman 2004 Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al.Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329(7477):1259-1264.
46. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
47. Scott 1995 Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. British Journal of Surgery 1995;82(8):1066-70.
48. Vardulaki 1999 Vardulaki KA, Prevost TC, Walker NM, Day NE, Wilmink AB, Quick CR, et al.Incidence among men of asymptomatic abdominal aortic aneurysms: estimates from 500 screen detected cases. Journal of Medical Screening 1999;6(1):50-4.
49. Wilmink 1998 Wilmink AB, Quick CR. Epidemiology and potential for prevention of abdominal aortic aneurysm. British Journal of Surgery 1998;85(2):155-62